Novel oral anticoagulants for stroke prevention in the geriatric population.
about
Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis.Bleeding events associated with a low dose (110 mg) versus a high dose (150 mg) of dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis
P2860
Novel oral anticoagulants for stroke prevention in the geriatric population.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel oral anticoagulants for stroke prevention in the geriatric population.
@en
type
label
Novel oral anticoagulants for stroke prevention in the geriatric population.
@en
prefLabel
Novel oral anticoagulants for stroke prevention in the geriatric population.
@en
P2860
P1476
Novel oral anticoagulants for stroke prevention in the geriatric population
@en
P2093
Daniel Kim
Richard Barna
P2860
P2888
P356
10.1007/S40256-013-0050-3
P577
2014-02-01T00:00:00Z
P6179
1019296977